Livsayis Becomes First siRNA Drug Approved for Generalized Myasthenia Gravis, Given as Just Four Shots a Year
The FDA approved Regeneron's Livsayis, a quarterly siRNA injection for adults with antibody-positive generalized myasthenia gravis, based on symptom improvements in the phase 3 NIMBLE trial.
Medical Daily ·